These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28604449)

  • 1. Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
    Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Jeong DH
    Int J Gynecol Cancer; 2017 Jul; 27(6):1228-1236. PubMed ID: 28604449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of histology on prognosis of patients with early-stage cervical cancer treated with radical surgery.
    Rudtanasudjatum K; Charoenkwan K; Khunamornpong S; Siriaunkgul S
    Int J Gynaecol Obstet; 2011 Nov; 115(2):183-7. PubMed ID: 21885048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.
    Wu SG; Sun JY; He ZY; Chen QH; Zhou J
    J Gynecol Oncol; 2017 Nov; 28(6):e81. PubMed ID: 29027399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
    Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
    Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis.
    Liang C; Su G; Sun L; Zhao H; Liu P; Chen C
    Int J Gynaecol Obstet; 2024 Jul; 166(1):272-281. PubMed ID: 38287671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB.
    Zhou J; Chen Y; Xu X; Yan D; Lou H
    Medicine (Baltimore); 2018 Jan; 97(2):e9323. PubMed ID: 29480826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
    Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
    Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
    J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
    Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
    Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Bean LM; Ward KK; Plaxe SC; McHale MT
    Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
    Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
    J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence patterns after radical hysterectomy in stage IB1-IIA cervical.
    Sittidilokratna K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
    Asian Pac J Cancer Prev; 2010; 11(2):499-502. PubMed ID: 20843140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
    Hanprasertpong J; Jiamset I; Atjimakul T
    Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
    Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of bulky pTIIB cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
    Okadome M; Nagayama R; Shimokawa M; Sonoda K; Shimamoto K; Saito T
    Int J Gynaecol Obstet; 2021 Apr; 153(1):56-63. PubMed ID: 33119174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Lee YJ; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Mar; 144(3):536-540. PubMed ID: 28108027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.